AMY EDWARDS: Open Payments
NPI 1497764260 · WAXAHACHIE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,126 in 55 payments from 13 companies in 2025. Trend: 2023 $642 · 2024 $1,663 · 2025 $1,126
Food & beverage: $1,126
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $229 |
| LEO Pharma Inc. | 8 | $197 |
| Regeneron Healthcare Solutions, Inc. | 11 | $187 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $136 |
| Janssen Biotech, Inc. | 3 | $86 |
| Galderma Laboratories, L.P. | 5 | $72 |
| UCB, Inc. | 2 | $61 |
| Lilly USA, LLC | 2 | $52 |
| PFIZER INC. | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30 |
Products named: SKYRIZI, ADBRY, ILUMYA, LIBTAYO, TREMFYA, DUPIXENT, NEMLUVIO, Bimzelx.
Industry payments across TX — which companies pay providers there.
